Pratyush Giri
North Terrace
Adelaide, SA, Australia
Adelaide, SA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis.
Journal: American journal of hematology
Published: November 21, 2025
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease.
Journal: Internal medicine journal
Published: July 04, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 18, 2025
A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study.
Journal: BMC cancer
Published: November 19, 2024
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial.
Journal: The Lancet. Oncology
Published: November 08, 2024
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: June 06, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry.
Journal: Leukemia & lymphoma
Published: February 20, 2024
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era.
Journal: Internal medicine journal
Published: November 15, 2023
Last Updated: 09/26/2026